Epilepsy is a common neurological disorder with a lifetime prevalence of 7.60 per 1000 persons [1]. In addition to seizures, epilepsy is characterized by the cognitive, psychological, and social consequences of the disease [2]. It has been estimated that about 50% of adults with epilepsy have at least one comorbid somatic or psychiatric condition [3,4]. Comorbidities can affect treatment decisions, as anti-seizure medications (ASM) can positively or negatively affect the comorbidities [5,6]. Comorbidities can also negatively affect quality of life (QoL) and prognosis of epilepsy [7,8].
11
SEP
SEP
0